Skip to Main Navigation

Mali - Multi-sectoral HIV/AIDS Project

Abstract*

The Multi-Sectoral HIV/AIDS Project objective is to support efforts to control the spread of the HIV/AIDS epidemic, and provide sustainable access to treatment, and care to people infected with, or affected by HIV/AIDS, by strengthening the national response to the epidemic, raising the level of awareness on HIV/AIDS through the implementation of a comprehensive sensitization plan targeting high risk groups, such as youth, sex workers and truck drivers...

* The project abstract is drawn from the PAD, SAR or PGD and may not accurately reflect the project's current nature

Show More

Development Objective

The revised project objective is to contribute to the recipient#s multisectoral efforts to control the spread of the HIV/AIDS epidemic by improving access to prevention, treatment and care particularly for the most-at-risk-population (MARP) and those infected with or affected by HIV/AIDS. This objective will be achieved by: (a) strengthening the Recipient#s national response to the HIV/AIDS epidemic by improving its evidence base, coordination, implementation, and monitoring and evaluation capacity; (b) raising the level of awareness on HIV/AIDS through the implementation of a comprehensive sensitization plan targeting MARP in particular; (c) providing access to testing and counseling facilities; and (d) providing access to treatment, care and psychosocial support to persons infected with or affected by HIV/AIDS.

Key Details

Project Details

  • P082957

  • Closed

  • Amadou Dem

  • N/A

  • Mali

  • April 21, 2004

  • (as of board presentation)

    June 17, 2004

  • December 30, 2004

  • US$ 25.50 million

  • B

  • Not Applicable

  • March 31, 2012

  • BANK APPROVED

  • March 10, 2015

  • Notes

Finances

Financing Plan (US$ Millions)

No data available.
Financier Commitments
IDA GRANT FOR HIV/AIDS 25.50
Borrower/Recipient 2.50

Total Project Financing (US$ Millions)

Product Line IBRD/IDA
IBRD Commitment N/A
IDA Commitment 25.50
IBRD + IDA Commitment 25.50
Lending Instrument
Grant Amount N/A
Total Project Cost** 28.00

Summary Status of World Bank Financing (US$ Millions) as of July 31, 2025

Download:
No data available.
Financier Approval Date Closing Date Principal Disbursed Repayments Interest, Charges & Fees

Detailed Financial Activity as of July 31, 2025

Download:
No data available.
Period Financier Transaction Type Amount (US$)
Sep 22, 2017 IDA-46250 Int Charges 18,335.94
Sep 22, 2017 IDA-46250 Int Charges 18,335.94
Mar 17, 2017 IDA-46250 Int Charges 14.33
Mar 17, 2017 IDA-46250 Int Charges 14.33
Mar 17, 2017 IDA-46250 Int Charges 17,820.39
Mar 17, 2017 IDA-46250 Int Charges 17,820.39
Mar 16, 2018 IDA-46250 Int Charges 435.95
Mar 16, 2018 IDA-46250 Int Charges 435.95
Mar 16, 2018 IDA-46250 Int Charges 18,856.97
Mar 16, 2018 IDA-46250 Int Charges 18,856.97
Sep 19, 2018 IDA-46250 Int Charges 292.07
Sep 19, 2018 IDA-46250 Int Charges 292.07
Sep 19, 2018 IDA-46250 Int Charges 18,454.56
Sep 19, 2018 IDA-46250 Int Charges 18,454.56
Mar 18, 2019 IDA-46250 Int Charges 16.50
Mar 18, 2019 IDA-46250 Int Charges 16.50
Mar 18, 2019 IDA-46250 Int Charges 37.86
Mar 18, 2019 IDA-46250 Int Charges 37.86
Mar 18, 2019 IDA-46250 Int Charges 18,366.68
Mar 18, 2019 IDA-46250 Int Charges 18,366.68
Sep 15, 2019 IDA-46250 Loan Repay 48.49
Sep 15, 2019 IDA-46250 Loan Repay 18.50
Sep 18, 2019 IDA-46250 Loan Repay 48,125.06
Sep 18, 2019 IDA-46250 Int Charges 18,071.94
Sep 18, 2019 IDA-46250 Int Charges 18,071.94
Mar 15, 2020 IDA-46250 Loan Repay 647.17
Mar 18, 2020 IDA-46250 Loan Repay 47,355.15
Mar 18, 2020 IDA-46250 Int Charges 2.99
Mar 18, 2020 IDA-46250 Int Charges 2.99
Mar 18, 2020 IDA-46250 Int Charges 17,818.53
Mar 18, 2020 IDA-46250 Int Charges 17,818.53
Oct 13, 2020 IDA-46250 Loan Repay 49,003.09
Oct 13, 2020 IDA-46250 Int Charges 3.07
Oct 13, 2020 IDA-46250 Int Charges 3.07
Oct 13, 2020 IDA-46250 Int Charges 17,089.45
Oct 13, 2020 IDA-46250 Int Charges 17,089.45
Mar 16, 2021 IDA-46250 Int Charges 28.89
Mar 16, 2021 IDA-46250 Int Charges 28.89
Mar 16, 2021 IDA-46250 Int Charges 18,285.70
Mar 16, 2021 IDA-46250 Int Charges 18,285.70
Mar 16, 2021 IDA-46250 Int Charges 1,206.69
Mar 16, 2021 IDA-46250 Int Charges 1,206.69
Mar 16, 2021 IDA-46250 Loan Repay 50,270.01
Sep 15, 2020 IDA-46250 Loan Repay 749.57
Mar 15, 2014 IDA-46250 Int Charges 20,232.44
Mar 15, 2014 IDA-46250 Int Charges 20,232.44
Mar 15, 2014 IDA-46250 Int Charges 270.89
Mar 15, 2014 IDA-46250 Int Charges 270.89
Sep 25, 2013 IDA-46250 Loan Cancel 893,593.94
Sep 15, 2013 IDA-46250 Int Charges 487.67
Sep 15, 2013 IDA-46250 Int Charges 487.67
Sep 15, 2013 IDA-46250 Int Charges 19,157.23
Sep 15, 2013 IDA-46250 Int Charges 19,157.23
Sep 15, 2013 IDA-46250 Int Charges 44.99
Sep 15, 2013 IDA-46250 Int Charges 44.99
Sep 15, 2013 IDA-46250 Int Charges 44.99
Sep 15, 2013 IDA-46250 Int Charges 44.99
Mar 18, 2015 IDA-46250 Int Charges 17,472.79
Mar 18, 2015 IDA-46250 Int Charges 17,472.79
Sep 15, 2014 IDA-46250 Int Charges 213.10
Sep 15, 2014 IDA-46250 Int Charges 19,778.75
Sep 15, 2014 IDA-46250 Int Charges 19,778.75
Mar 15, 2015 IDA-46250 Int Charges 604.26
Mar 15, 2015 IDA-46250 Int Charges 604.26
Sep 15, 2014 IDA-46250 Int Charges 213.10
Mar 16, 2016 IDA-46250 Int Charges 179.65
Mar 16, 2016 IDA-46250 Int Charges 179.65
Sep 17, 2015 IDA-46250 Int Charges 17,682.46
Sep 17, 2015 IDA-46250 Int Charges 17,682.46
Sep 15, 2015 IDA-46250 Int Charges 749.53
Sep 15, 2015 IDA-46250 Int Charges 749.53
Sep 21, 2016 IDA-46250 Int Charges 115.16
Sep 21, 2016 IDA-46250 Int Charges 115.16
Sep 21, 2016 IDA-46250 Int Charges 18,383.09
Sep 21, 2016 IDA-46250 Int Charges 18,383.09
Mar 16, 2016 IDA-46250 Int Charges 18,245.31
Mar 16, 2016 IDA-46250 Int Charges 18,245.31
Sep 22, 2017 IDA-46250 Int Charges 77.08
Sep 15, 2021 IDA-46250 Loan Repay 49,638.49
Sep 15, 2021 IDA-46250 Int Charges 1.06
Sep 15, 2021 IDA-46250 Int Charges 1.06
Sep 15, 2021 IDA-46250 Int Charges 17,961.08
Sep 15, 2021 IDA-46250 Int Charges 17,961.08
Sep 15, 2021 IDA-46250 Loan Repay 511.59
Oct 4, 2022 IDA-46250 Int Charges 15,968.25
Jul 12, 2022 IDA-46250 Loan Repay 46,061.06
Jul 12, 2022 IDA-46250 Int Charges 16,409.24
Jul 12, 2022 IDA-46250 Int Charges 16,409.24
Jul 12, 2022 IDA-46250 Int Charges 85.36
Jul 12, 2022 IDA-46250 Int Charges 85.36
Sep 15, 2022 IDA-46250 Loan Repay 4,663.81
Oct 4, 2022 IDA-46250 Loan Repay 40,660.76
Oct 4, 2022 IDA-46250 Int Charges 110.42
Oct 4, 2022 IDA-46250 Int Charges 110.42
Oct 4, 2022 IDA-46250 Int Charges 15,968.25
Apr 6, 2023 IDA-46250 Int Charges 16,497.52
Apr 6, 2023 IDA-46250 Int Charges 16,497.52
Apr 6, 2023 IDA-46250 Loan Repay 46,475.47
Apr 6, 2023 IDA-46250 Int Charges 16.84
Apr 6, 2023 IDA-46250 Int Charges 16.84
Oct 16, 2023 IDA-46250 Int Charges 40.48
Oct 16, 2023 IDA-46250 Int Charges 40.48
Oct 16, 2023 IDA-46250 Loan Repay 46,082.16
Oct 16, 2023 IDA-46250 Int Charges 19.76
Oct 16, 2023 IDA-46250 Int Charges 19.76
Oct 16, 2023 IDA-46250 Int Charges 15,898.34
Oct 16, 2023 IDA-46250 Int Charges 15,898.34
Mar 15, 2023 IDA-46250 Loan Repay 936.58
Mar 15, 2024 IDA-46250 Loan Repay 2,041.80
Mar 15, 2024 IDA-46250 Loan Repay 5,049.97
Apr 18, 2024 IDA-46250 Loan Repay 39,299.43
Apr 18, 2024 IDA-46250 Int Charges 29.91
Apr 18, 2024 IDA-46250 Int Charges 29.91
Apr 18, 2024 IDA-46250 Int Charges 15,804.26
Apr 18, 2024 IDA-46250 Int Charges 15,804.26
Jun 17, 2004 IDA-H0990 Loan Commitment 25,500,000.00
May 19, 2009 IDA-46250 Loan Commitment 6,000,000.00
Sep 22, 2017 IDA-46250 Int Charges 77.08

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name Review Date
Procurement Moderately Satisfactory 2011-12-28
Progress towards achievement of PDO Satisfactory 2011-12-28
Overall Implementation Progress (IP) Moderately Satisfactory 2011-12-28
Counterpart Funding Satisfactory 2011-12-28
Project Management Moderately Satisfactory 2011-12-28
Monitoring and Evaluation Satisfactory 2011-12-28
Financial Management Moderately Satisfactory 2011-12-28

COMPLETION RATINGS

INDICATORIMPLEMENTATION COMPLETION & RESULTS REPORT: 03-01-2013
OutcomesModerately Satisfactory
Risk to Development OutcomeSubstantial
Bank PerformanceModerately Satisfactory
Borrower PerformanceModerately Satisfactory
Government PerformanceModerately Satisfactory
Implementing AgencyModerately Satisfactory

INDEPENDENT EVALUATION RATINGS

INDICATORICR REVIEW: 12-30-2013PROJECT PERFORMANCE ASSESSMENT REPORT:
Outcome RatingModerately Satisfactory N/a
Risk To Development OutcomeSignificantN/a
Bank PerformanceModerately SatisfactoryN/a
Borrower PerformanceModerately SatisfactoryN/a
Government PerformanceModerately SatisfactoryN/a
Implementing AgencyModerately SatisfactoryN/a
Icr QualitySatisfactoryN/a
M&e QualityModestN/a

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATORBASELINECURRENTTARGET
  • At least 15,000 orphans attend school regularly by July 2011Value15,0001029915,000
    DateDecember 30, 2004March 15, 2012March 31, 2012
    CommentNot achieved. Activities supported only at the beginning school
  • At least 9,000 PLWA medically eligible for treatment (CD4 count less than 200) are under ARV treatment by July 2011Value1,073239639,000
    DateDecember 30, 2004March 15, 2012March 31, 2012
    CommentAchieved by the program (not only MAP). The MAP is providing ARV through private pharmacies which is a major innovation. It isalsoproviding biological monitoring which is required prior to ARV treatmentThe Global Fund was the main financier for ARVs. This was not planned during project preparation. The project did no reach theoriginal indicator because the government decided to mainly use the Global Fund resources to provide ARVs.
  • 55000 Persons aged 15 and older received counseling and testing (VCT) for HIV and received their test results (new indicator)Valuen/a9387055,000
    DateDecember 30, 2004March 15, 2012March 31, 2012
    CommentAchieved
  • 15000 commercial sex workers and other MARP receiving services from subprojectsValuen/a860015,000
    DateDecember 30, 2004June 12, 2009July 30, 2011
    Comment

INTERMEDIATE RESULTS INDICATORS

INDICATORBASELINECURRENTTARGET
  • 60% of HIV+ pregnant women assisted for prenatal care received ARV prophylaxis (PTME) by end of projectValue60%67%60%
    DateDecember 30, 2004March 15, 2012March 31, 2012
    CommentAchieved by the program (not only the MAP)
  • 257 reference centers (circles & communes) and CSCOM offer testing and counseling by end of projectValue257320257
    DateDecember 30, 2004March 15, 2012March 31, 2012
    CommentAchieved
  • 160 reference centers (circles & communes) and CSCOM structures have means to dispose of medical waste by the end of the projectValuena60160
    DateDecember 30, 2004September 1, 2011March 31, 2012
    CommentNot achieved. Activities ongoing. Equipments have been procured and are being installed
  • At least 100 enterprises and business associations have implemented HIV/AIDS action plan by the end of the projectValue677100
    DateDecember 30, 2004December 31, 2010July 30, 2011
    CommentNot achieved. Activities ongoing
  • Number of private centers offering VCT services increased from 15 to 55Value152225
    DateDecember 31, 2004December 31, 2010July 30, 2011
    CommentNot achieved. Activities ongoing
  • 7000 patients with access to treatment monitoring services by private laboratory (new indicator)Valuen/a7000
    DateDecember 30, 2004June 12, 2009December 30, 2011
    CommentAchieved under the original project
  • At least 25 sub-projects implemented among commercial sex workers and/or high risk groups (truck drivers, ambulatory vendors, military/police, etc) annuallyValue25050
    DateDecember 30, 2004December 31, 2010July 30, 2011
    CommentAchieved